Clinical Trial Update: A Study of Iron Oligosaccharide in CHF Patients [Phase 3]

View source ↗

Summary

Phase 3 study of iron oligosaccharide in congestive heart failure patients has completed. The trial was sponsored by Pharmacosmos A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Iron Oligosaccharide (iron oligosaccharide)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Heart Failure, Congestive | Phase 3 | Status: COMPLETED